A Phase II Study of Preradiotherapy Chemotherapy Followed by Hyperfractionated Radiotherapy for Newly Diagnosed High-Risk Medulloblastoma/Primitive Neuroectodermal Tumor: A Report From the Children's Oncology Group (CCG 9931)
- 15 July 2009
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 74 (4), 1006-1011
- https://doi.org/10.1016/j.ijrobp.2008.09.019
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Phase III Study of Craniospinal Radiation Therapy Followed by Adjuvant Chemotherapy for Newly Diagnosed Average-Risk MedulloblastomaJournal of Clinical Oncology, 2006
- Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: Results of the French M-SFOP 98 protocolInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Importance of radiation time and dose factors on outcome for childhood medulloblastoma*Australasian Radiology, 2005
- Outcome for patients with metastatic (M2–3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapyEuropean Journal Of Cancer, 2005
- Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning studyActa Oncologica, 2005
- Reducing Toxicity from Craniospinal IrradiationThe Cancer Journal, 2004
- Preradiation chemotherapy of children and young adults with malignant brain tumors: Results of the german pilot trial HIT'88/'89.Klinische Padiatrie, 1998
- Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumorsInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Preradiation chemotherapy in advanced medulloblastoma a pediatric oncology group pilot studyCancer, 1993
- High-dose Carboplatin in Combination with Etoposide (JET Regimen) for Childhood Brain TumorsJournal of Pediatric Hematology/Oncology, 1990